tiprankstipranks

SI-Bone price target lowered to $19 from $21 at Morgan Stanley

Morgan Stanley lowered the firm’s price target on SI-Bone to $19 from $21 and keeps an Overweight rating on the shares after what the firm calls “another solid quarter with positive steps towards breakeven.” Management having committed to positive adjusted EBITDA in Q4 and outlining the path towards full-year 2025 positive EBITDA “should be well-received,” the analyst tells investors.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue